News
-
-
-
-
-
-
-
PRESS RELEASE
Eurobattery Minerals publishes Q2 report for 2025 at the same time as it launches work at the San Juan Tungsten Project
Eurobattery Minerals AB publishes Q2 2025 interim report showcasing strategic projects in Europe for critical raw materials supply. Financial highlights and key developments included -
-
-
PRESS RELEASE
Jaguar Health Family Company Napo Pharmaceuticals to Meet with FDA to Discuss Potential Regulatory Pathways for Crofelemer for Treatment of Ultrarare Pediatric Indication Microvillus Inclusion Disease (MVID)
Napo Pharmaceuticals plans FDA meeting to discuss crofelemer clinical program for MVID, with proof-of-concept results reducing TPN. Abstract accepted for NASPGHAN 2025 Annual Meeting in Chicago